Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Financial Data
-
31st Mar 21 Source: CRO
- €2.6 billion turnover
-
€312.4 million
profit - 199 employees
-
31st Mar 20 Source: CRO
- €446.5 million turnover
-
-€134.3 million
profit - 183 employees
- 13 more years available »
Ranking
By Turnover
(€2.6 billion)- 48th in Top Companies
- 7th in Pharma
By Employees
(199)- 604th in Top Companies
- 55th in Pharma
-
- 199
- €2.6 billion
Employees
- Susan Hynes Vice President}
Latest News
- May 21 Consumer giant Procter & Gamble sells last Irish manufacturing plant
- May 21 Nama clashes with Fingal council over lands with space for up to 7,000 new homes
- May 20 Attempt by investors to appoint inspector to firm ‘without precedent’, court hears
- May 20 Amarenco and SSE among groups to win green Eirgrid contracts
- May 20 Cerberus collected €113m last year from Irish loans it bought after the 2008 crash